Luye Pharma (2186.HK) traded up 0.63 % during a 24 hours period ending at 12:37 AM Central Europe on Tuesday 27th. One Luye Pharma stock can currently be bought for about HKD 1.61 on popular exchanges. Current supply of Luye Pharma stocks is 4 bn. Luye Pharma has a current market capitalization of HKD 6.4 bn and approximately HKD 58.7 mn worth of Luye Pharma was traded on exchanges in the last 24 hours. Since last month end, Luye Pharma has traded -15.65 % down. Simple moving average of last 200 days is at HKD 2.29. The highest price of past 52 weeks was recorded at HKD 3.27 on 11/03/2025. 52 weeks low was at HKD 1.55 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Mayair China (688376.SS) traded flat 0 % and now trades at CNY 46.56. Mayair China has a market capitalisation of CNY 6.5 bn.
Guochuang Software (300520.SZ) traded flat 0 % and now trades at CNY 22.71. Current market capitalisation for Guochuang Software is CNY 6.5 bn.
Zkteco (301330.SZ) traded flat 0 % and now trades at CNY 27.05. Zkteco has a market capitalisation of CNY 6.5 bn. Current price/earnings ratio for Zkteco is 29.36.
Zhejiang Asia-pacific Mech (002284.SZ) traded flat 0 % and now trades at CNY 8.79. Zhejiang Asia-pacific Mech has a market capitalisation of CNY 6.5 bn. Current price/earnings ratio for Zhejiang Asia-pacific Mech is 11.67.
Henan Yicheng New Energy C (300080.SZ) traded flat 0 % and now trades at CNY 3.52. Henan Yicheng New Energy C has a market capitalisation of CNY 6.5 bn.
About Luye Pharma
The Luye Pharma Group Ltd is a health care company operating in the pharmaceutical industry, specializing in research and development, production, and sales of drugs for orthopedics, neurology, gastroenterology, and hepatology. Additionally, the company sells active ingredients, R&D results, and patents of new drugs, and provides research services on a contractual basis. You can find more information about their operations on their website, www.luye.cn , and they are listed on the Hong Kong Stock Exchange. Their Initial Public Offering (IPO) took place on May 5, 2004.
